J.M. Smucker Company (SJM) Q4 2025 (USD): EPS 2.38 (exp. 2.27), Revenue 2.34bln (exp. 2.32bln)

J.M.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Victory Capital offers to buy Janus Henderson Group (JHG) for USD 57.04/shr, according to Bloomerg TV

US Democratic Senators highlighted conflict of interest concerns re. Commerce Secretary Lutnick's former Co. Cantor Fitzgerald in a deal relating to USA Rare Earth (USAR), CNBC reports

J.M. Smucker Company (SJM) Q4 2025 (USD): EPS 2.38 (exp. 2.27), Revenue 2.34bln (exp. 2.32bln)

Bristol Myers Squibb's (BMY) Izalontamab brengitecan (Iza-bren) met its dual primary endpoints of progression free survival and overall survival in an interim analysis of a Phase 3 trial

Viatris Inc. (VTRS) Q4 2025 (USD): EPS 0.57 (exp. 0.53), Revenue 3.69bln (exp. 3.53bln)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Appoints two new independent directors and follows constructive engagement with Elliott.
Context

Smucker's latest earnings report reflects a positive beat on both earnings per share (EPS) and revenue, indicating stronger-than-expected financial health in a competitive market. The appointment of two independent directors following engagement with Elliott suggests potential strategic shifts or governance improvements, which may enhance investor confidence moving forward. This outcome could impact not just SJM but also share sentiment in the packaged foods sector and related equities.

Related headlines

The whole workspace, free to try.

Try it free